Latest Organofluorides Stories
MIAMI and NEW YORK, Oct.
Risperdal Lawsuit Claims Continue With Meeting Scheduled In October For Gynecomastia Lawsuits Pending Litigation Columbus, OH (PRWEB) October 11, 2014
The Firm is representing numerous Risperdal lawsuit clients in the Pennsylvania litigation, all of whom allegedly developed gynecomastia, or male breast growth, due to their use of the atypical
DelMar Pharmaceuticals Presents Data at AACR's New Horizons in Cancer Research Conference in Shanghai, China VANCOUVER, British Columbia, MENLO PARK, Calif. and SHANGHAI, Oct.
NEW YORK, Oct.
Sales of Breast Cancer Therapies are Expected to Almost Double Through 2023, Fueled by Growth in Several Distinct Market Segments, According to Findings from Decision Resources Group BURLINGTON,
NORTHBROOK, Ill., Oct.
- Product strengthens growing antiretroviral franchise in the U.S. - PITTSBURGH, Oct. 3, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced the U.S.
DuPont Distribution Spans United States and Reaches 40 Countries in Europe, Middle-East and Africa WILMINGTON, Del., Oct. 6, 2014 /PRNewswire/ -- Kathryn K.
- A trick or prank.